GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SymBio Pharmaceuticals Ltd (TSE:4582) » Definitions » Notes Receivable

SymBio Pharmaceuticals (TSE:4582) Notes Receivable : 円0 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is SymBio Pharmaceuticals Notes Receivable?

SymBio Pharmaceuticals's Notes Receivable for the quarter that ended in Mar. 2024 was 円0 Mil.


SymBio Pharmaceuticals Notes Receivable Historical Data

The historical data trend for SymBio Pharmaceuticals's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SymBio Pharmaceuticals Notes Receivable Chart

SymBio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SymBio Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SymBio Pharmaceuticals Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


SymBio Pharmaceuticals Notes Receivable Related Terms

Thank you for viewing the detailed overview of SymBio Pharmaceuticals's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


SymBio Pharmaceuticals (TSE:4582) Business Description

Traded in Other Exchanges
Address
5-23-7 Shimbashi, San-Ei Building, 8th Floor, Minato-ku, Tokyo, JPN, 105-0004
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in manufacturing and commercializing drugs for oncology, hematology, and pain management.

SymBio Pharmaceuticals (TSE:4582) Headlines

No Headlines